Search clinical trials for: Iscomatrix adjuvant

Total 8302 results

Zefen Xiao

Active, not recruiting

Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma

Esophageal Cancer | Esophageal Neoplasms

China
Jiangsu Cancer Institute & Hospital

Terminated

NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation

Nasopharyngeal Carcinoma

China
Novavax

Completed

Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA Vaccines

COVID-19

United States
Campus Bio-Medico University

Completed

4 Versus 6 Courses of Adjuvant Chemotherapy in LACC Patients Previously Treated With NACT Plus Radical Surgery

Uterine Cervical Neoplasms

Italy
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection

Diarrhea | Clostridium Difficile Infection

United Kingdom, United States
Cancer Institute and Hospital, Chinese Academy...

Unknown

Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer

Breast Cancer

China
National Institute of Allergy and Infectious Diseases...

Completed

H5N1 Mix and Match With AS03

Influenza

United States
Institut de Cancérologie de Lorraine

Active, not recruiting

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

Pancreatic Carcinoma

France
Shiga University
Tokyo University

Completed

Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Japan
Altimmune, Inc.

Completed

Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B

Hepatitis B

Korea, Republic of, United Kingdom
Colby Pharmaceutical Company

Completed

Safety, Tolerability and Immunogenicity of Fluzone® With and Without JVRS-100 in Elderly Subjects

Influenza
Technical University of Munich
German Cancer Aid

Recruiting

Respiratory Training and Relaxation Techniques to Improve Adjuvant Radiation Therapy in DIBH in Breast Cancer (B-REST)

Breast Cancer | Radiotherapy | Relaxation | Breathholding

Germany
Medicago
Mitsubishi Tanabe Pharma Corporation

Terminated

Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19）

SARS-CoV-2 Infection

Japan
Institut Cancerologie de l'Ouest

Completed

Interest of Touch-massage in Hospital Day Care (TOMAS)

Breast Neoplasm Malignant Female

France
University of Wisconsin, Madison
National Cancer Institute (NCI)

Completed

Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

Head and Neck Cancer | Radiation Toxicity | Long-term Effects Secondary to Cancer Therapy in Adults | Oral Complications of Radiation Therapy
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

United States
Centre Oscar Lambret

Active, not recruiting

Carboplatin-Paclitaxel Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer (ACCRAPAN)

Cervical Cancer | Locally Advanced Cancer

France
WellSpan Health

Withdrawn

Rates and Severity of PONV for Neuromuscular Block Reversal in Patients Receiving Gastric Bypass Bariatric Surgery

Bariatric Surgery Candidate
Seoul National University Bundang Hospital

Completed

The Effect of Deep Neuromuscular Block on Surgical Condition During Laparoscopic Colorectal Surgery (DEEPCOL)

Neuromuscular Blockade
Cinnagen
Vaxine Pty Ltd

Completed

Immunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 Years

COVID-19

Iran, Islamic Republic of
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate the Safety and Immunogenicity of H7N9 Influenza Vaccine (AT-501) in Healthy Adult Subjects

H7N9 Influenza Vaccine

Taiwan
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)

HIV Infections

United States, South Africa
Craig L Slingluff, Jr

Completed

Pilot Study for the Evaluation of the Efficacy of Vaccination With Autologous Tumor Cells Plus Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) - in - Adjuvant, Followed by Systemic Low-dose-interleukin-2 (IL-2) Administration, in Patients With High Risk Melanoma (MEL37)

Melanoma

United States
Saint John's Cancer Institute
Melanoma Research Alliance

Terminated

Stage IV Surgery Versus Best Medical Therapy (STG4SURG)

Stage IV Resectable Melanoma

United States, Australia, Israel, Italy, Netherlands
Novavax

Completed

RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly

Respiratory Syncytial Virus (RSV)

United States
Suzhou Municipal Hospital

Recruiting

Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease)

Cervical Cancer

China
Sun Yat-sen University
Zhejiang Cancer Hospital; First People's Hospital of Hangzhou; The First Affiliated... and other collaborators

Recruiting

Neoadjuvant Chemoradiotherapy vs. Chemotherapy With Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer (Neo-CRAG)

Gastric Cancer

China
Sun Yat-sen University

Active, not recruiting

TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Davita Clinical Research
Baxter Healthcare Corporation

Terminated

Adjuvant Peritoneal Dialysis on a Background of Thrice-Weekly Hemodialysis

Functionally Anuric | Hemodialysis/Peritoneal Dialysis
Institut Paoli-Calmettes

Completed

NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer (NEOPAC)

Pancreas Cancer

France
National Institute of Allergy and Infectious Diseases...

Completed

H5N1 Mix and Match With MF59

Influenza

United States
Sun Yat-sen University
Guangdong Provincial People's Hospital; Second Military Medical University

Unknown

Efficacy and Safety Study of Neoadjuvant in Treating Patients With Resectable Local Recurrent Rectal Cancer (NARC)

Rectal Cancer

China
National Cancer Institute (NCI)

Completed

Brachytherapy in Treating Patients With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
Novavax

Completed

Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine

Covid19 | SARS-CoV Infection

Australia
NYU Langone Health
MOUNT SINAI HOSPITAL

Withdrawn

A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma

Glioma | Glioblastoma

United States
Bionor Immuno AS

Completed

Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART

HIV-1 Infection

Norway
PepTcell Limited
Norwegian Institute of Public Health; University Medical Center Groningen; University... and other collaborators

Completed

A Randomised, Double-blind, Placebo-controlled Phase IIb Trial to Test FLU-v Vaccine

Influenza

Netherlands
Novavax

Completed

Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines (COVID-19)

COVID-19 | SARS CoV 2 Infection

Australia
Mahidol University

Completed

Efficacy of Intravenous Glyco-P® in Patients Undergoing Procedure That Require Anesthesia Service

Bradycardia | Hypersalivation | Prevention of Drooling | Reversal of Muscle Relaxants

Thailand
Gustave Roussy, Cancer Campus, Grand Paris
Merck Sharp & Dohme LLC

Not yet recruiting

Study Evaluating Pembrolizumab +/- Olaparib in TLS Positive Selected Resectable STS Followed by Adjuvant Pembrolizumab (NeoSarc)

Cancer

France
Beijing Tiantan Hospital
ZhongSheng BioTech Inc.

Active, not recruiting

Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery

Glioblastoma Multiforme of Brain

China
Sanofi Pasteur, a Sanofi Company

Completed

A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months

Influenza | Swine-origin A/H1N1 Influenza

Finland
Roswell Park Cancer Institute
NeuroEndocrine Tumor Research Foundation (NETRF)

Recruiting

Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors

Lung Atypical Carcinoid Tumor | Metastatic Pancreatic Neuroendocrine Tumor | Lung Typical Carcinoid Tumor

United States
Ludwig-Maximilians - University of Munich
Eli Lilly and Company; Sanofi; Novartis; AstraZeneca; Chugai Pharma USA; Janssen Diagnostics...

Completed

Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial

Breast Neoplasms

Germany
Boehringer Ingelheim

Completed

Morbid Rates After Spiriva Chronic Obstructive Pulmonary Disease (COPD) Protocol Change

Pulmonary Disease, Chronic Obstructive

Brazil
Children's Hospital of Philadelphia

Terminated

Pharmacokinetics and Pharmacodynamics of Pentobarbital in Neonates, Infants, and Children Following Open Heart Surgery

Cardiac Surgical Procedures

United States
Akron Children's Hospital

Completed

Sedation for Brainstem Evoked Auditory Response (BEAR) Testing Using Intravenous Pentobarbital

Childrens 0 to 18 Years of Age Who Require Moderate Sedation

United States
Assaf-Harofeh Medical Center
International Diabetes Federation; Israeli MOH

Withdrawn

Scopolamine Treatment for Patients With Organophosphate Poisoning

Neurotoxicity Syndromes

Israel
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Air Force Military Medical University, China; Guizhou Center for Disease Control... and other collaborators

Unknown

Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age

Meningitis | Meningococcal Infections | Meningococcal Meningitis

China
Novartis Pharmaceuticals

Completed

Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer (EarLEE-1)

Breast Cancer

United States

Search clinical trials for: Iscomatrix adjuvant

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations